# Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

> **NCT03018691** · PHASE2 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 73 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** OPA-15406
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03018691
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03018691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03018691, "Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03018691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*